« Previous highlight slide

Next highlight slide »

  • MediaPharma S.r.l.

    A Company focused on the discovery, development and commercialization of monoclonal antibodies for the diagnosis and treatment of cancer and other diseases with unmet medical need.

  • Personalized medicine

    At the present, one of the major problems in cancer treatment lies in the lack of suitable assays to select patients more likely to respond to a given anticancer therapy

MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.

Questa pagina è HTML valido Questa pagina è CSS valido Questo sito à valido secondo i criteri per l'accessibilit` stabiliti dal W3C Questa feed RSS à valido Credits